Coronary disease: The genetics of heart attack

Heart

Volumn 92, Issue 6, 2006, Pages 855-861

  Topol, Eric J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 37; LEUKOTRIENE A4 HYDROLASE; LIPOXYGENASE; MYOCYTE ENHANCER FACTOR 2; PROTEOME; STROMELYSIN; TRANSCRIPTOME;

ATHEROSCLEROSIS; AUTOSOMAL DOMINANT INHERITANCE; CORONARY ARTERY DISEASE; ENZYME ACTIVATION; GENE IDENTIFICATION; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEART INFARCTION; HUMAN; HUMAN GENOME; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECESSIVE GENE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; FORECASTING; GENETIC PREDISPOSITION; GENETICS; GENOME; PEDIGREE;

FORECASTING; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); MYOCARDIAL INFARCTION; PEDIGREE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33744481019     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.060202     Document Type: Review

References (20)

1. Hirschhorn JN, Lohmueller K, Byrne E, et al. A comprehensive review of genetic association studies. Genetics in Medicine 2002;4:45-61. A detailed review emphasising false positive studies of single nucleotide polymorphisms.
2. McCarthy JJ, Parker A, Moliterno DJ, et al for the GENEQUEST Investigators. Large-scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet 2004;41:334-41. First high-throughput study of variants for myocardial infarction which would now be considered of limited scope.
3. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002;347:1916-23. Extensive genotyping of patients with sporadic myocardial infarction demonstrating four gender-specific variants that were statistically significant.
4. Shiffman D, Ellis SG, Rowland CM, et al. Identification of four gene variants associated with myocardial infarction. Am J Human Genet 2005;77: 596-605. Recent whole genome SNP study of 6891 genes identifying four variants associated with myocardial infarction.
5. Wang Q, Rao S, Shen G-Q, et al. Premature myocardial infarction novel susceptibility locus on chromosome 1p34-36 identified by genome-wide linkage analysis. Am J Human Genet 2004;74:262-71. The GeneQuest genome wide linkage study that demonstrated a very substantial chromosome linkage peak for myocardial infarction.
6. Helgodottir A, Manolescu A, Thorleifsson G, et al. The gene encoding 5-lipoxygenase activating protein (FLAP) confers risk of myocardial infarction and stroke. Nat Genet 2004;36:233-39.
7. Wang L, Fan C, Topol SE, et al. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 2003;302:1578-81.
8. Ozaki K, Ohnishi Y, Iida A, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002;32:650-4.
9. Ozaki K, Inoue K, Sato H, et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 2004;429:72-5.
10. Hinds DA, Stuve LL, Nilsen GB, et al. Whole-genome patterns of common DNA variation in three human populations. Science 2005;307:1072-9. First edition of the haplotype map with analysis of more than 1.5 million SNPs in 71 individuals of diverse geographic ancestry.
11. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108.
12. Braun A, Trigatti BL, Post MJ, et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 2002;90:270-6.
13. Hakonarson H, Thorvaldsson S, Helgadottir A, et al. A randomized, placebo-controlled, crossover trial of an inhibitor of the 5-lipoxygenase activating protein (FLAP), DG-031, shows reduction in concentrations of biomarkers of risk of myocardial infarction in patients with coronary artery disease and at-risk variants of the FLAP and leukotriene A4 (LTA4) hydrolase genes. JAMA 2005;293:2245-56. First gene-specific trial in cardiovascular medicine testing a FLAP blocker in patients with gain-of-function FLAP genetic variant.
14. Helgadottir A, Manolescu A, Helgason A, et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnic specific risk of myocardial infarction. Nat Genet 2006;38:68-74.
15. Bhagavatula MRK, Fan C, Shen G-Q, et al. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet 2004;13:3181-8. Demonstration of point MEF2A mutations in 1.6% of sporadic MI individuals.
16. Weng L, Kavaslar N, Ustaszewska, et al. Lack of MEF 2A mutations in coronary artery disease. J Clin Invest 2005;115:1016-20.
17. Wang Q, Rao S, Topol EJ. Miscues on the "lack of MEF2A mutations" in coronary artery disease. J Clin Invest 2005;115:1399-400.
18. Gonzalez P, Garcia-Castro M, Reguero JR, et al. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction. J Med Genet 2006;43:167-9. Replication and extension of MEF2A findings via point mutation and its association with myocardial infarction.
19. Freedman ML, Reich D, Penney KL, et al. Assessing the impact of population stratification on genetic association studies. Nat Genet 2004;36:388-93.
20. Fischer M, Broeckel U, Holmer S, et al. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 2005;111:855-62. Angiographic study of siblings affected with MI that demonstrates remarkable concordance of location of atherosclerosis in the coronary anatomy.